nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—Benazepril—Lisinopril—dilated cardiomyopathy	0.551	1	CrCrCtD
Imipramine—KCND3—endocardium—dilated cardiomyopathy	0.039	0.292	CbGeAlD
Imipramine—KCNH2—purkinje fiber—dilated cardiomyopathy	0.0279	0.209	CbGeAlD
Imipramine—KCNH2—endocardium—dilated cardiomyopathy	0.0144	0.108	CbGeAlD
Imipramine—Drug fever—Spironolactone—dilated cardiomyopathy	0.0102	0.0698	CcSEcCtD
Imipramine—SLC6A2—sympathetic nervous system—dilated cardiomyopathy	0.00631	0.0473	CbGeAlD
Imipramine—HTR7—pulmonary artery—dilated cardiomyopathy	0.00625	0.0468	CbGeAlD
Imipramine—HTR7—sympathetic nervous system—dilated cardiomyopathy	0.00608	0.0455	CbGeAlD
Imipramine—Breast enlargement—Spironolactone—dilated cardiomyopathy	0.00523	0.0359	CcSEcCtD
Imipramine—HTR2A—pulmonary artery—dilated cardiomyopathy	0.0039	0.0292	CbGeAlD
Imipramine—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.00379	0.0284	CbGeAlD
Imipramine—KCND2—cardiac ventricle—dilated cardiomyopathy	0.00376	0.0282	CbGeAlD
Imipramine—KCND3—cardiac ventricle—dilated cardiomyopathy	0.00328	0.0246	CbGeAlD
Imipramine—KCND3—myocardium—dilated cardiomyopathy	0.00308	0.0231	CbGeAlD
Imipramine—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00304	0.0208	CcSEcCtD
Imipramine—Sleep disturbance—Lisinopril—dilated cardiomyopathy	0.00247	0.017	CcSEcCtD
Imipramine—KCND2—heart—dilated cardiomyopathy	0.00247	0.0185	CbGeAlD
Imipramine—Inappropriate antidiuretic hormone secretion—Lisinopril—dilated cardiomyopathy	0.00238	0.0164	CcSEcCtD
Imipramine—Ataxia—Spironolactone—dilated cardiomyopathy	0.00232	0.0159	CcSEcCtD
Imipramine—KCND3—heart—dilated cardiomyopathy	0.00215	0.0161	CbGeAlD
Imipramine—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00211	0.0145	CcSEcCtD
Imipramine—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.00205	0.0141	CcSEcCtD
Imipramine—Aprindine—SCN5A—dilated cardiomyopathy	0.00198	0.264	CrCbGaD
Imipramine—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00196	0.0135	CcSEcCtD
Imipramine—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0019	0.013	CcSEcCtD
Imipramine—KCND3—cardiac atrium—dilated cardiomyopathy	0.00184	0.0138	CbGeAlD
Imipramine—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.00181	0.0124	CcSEcCtD
Imipramine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00177	0.0122	CcSEcCtD
Imipramine—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.00167	0.0115	CcSEcCtD
Imipramine—Oxcarbazepine—SCN5A—dilated cardiomyopathy	0.00154	0.205	CrCbGaD
Imipramine—Alopecia—Spironolactone—dilated cardiomyopathy	0.00151	0.0103	CcSEcCtD
Imipramine—Vascular purpura—Furosemide—dilated cardiomyopathy	0.0015	0.0103	CcSEcCtD
Imipramine—Purpura—Furosemide—dilated cardiomyopathy	0.00139	0.00955	CcSEcCtD
Imipramine—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00139	0.00951	CcSEcCtD
Imipramine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00138	0.00945	CcSEcCtD
Imipramine—Malaise—Spironolactone—dilated cardiomyopathy	0.00134	0.00919	CcSEcCtD
Imipramine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00133	0.00912	CcSEcCtD
Imipramine—Urinary retention—Furosemide—dilated cardiomyopathy	0.00127	0.00875	CcSEcCtD
Imipramine—Discomfort—Spironolactone—dilated cardiomyopathy	0.00125	0.00857	CcSEcCtD
Imipramine—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00122	0.00841	CcSEcCtD
Imipramine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00122	0.00838	CcSEcCtD
Imipramine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00121	0.00831	CcSEcCtD
Imipramine—KCNH2—cardiac ventricle—dilated cardiomyopathy	0.00121	0.00907	CbGeAlD
Imipramine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00119	0.00814	CcSEcCtD
Imipramine—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00116	0.00798	CcSEcCtD
Imipramine—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00115	0.00788	CcSEcCtD
Imipramine—KCNH2—myocardium—dilated cardiomyopathy	0.00114	0.00853	CbGeAlD
Imipramine—SLC22A4—heart—dilated cardiomyopathy	0.00114	0.00851	CbGeAlD
Imipramine—CHRM2—heart—dilated cardiomyopathy	0.0011	0.00825	CbGeAlD
Imipramine—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00108	0.00745	CcSEcCtD
Imipramine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00108	0.00739	CcSEcCtD
Imipramine—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00107	0.00735	CcSEcCtD
Imipramine—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00106	0.00726	CcSEcCtD
Imipramine—Carbamazepine—SCN5A—dilated cardiomyopathy	0.00105	0.14	CrCbGaD
Imipramine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00105	0.00718	CcSEcCtD
Imipramine—Drowsiness—Furosemide—dilated cardiomyopathy	0.00103	0.00709	CcSEcCtD
Imipramine—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00103	0.00705	CcSEcCtD
Imipramine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000998	0.00685	CcSEcCtD
Imipramine—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.000998	0.00685	CcSEcCtD
Imipramine—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000977	0.00671	CcSEcCtD
Imipramine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000964	0.00662	CcSEcCtD
Imipramine—Urticaria—Spironolactone—dilated cardiomyopathy	0.000962	0.0066	CcSEcCtD
Imipramine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000957	0.00657	CcSEcCtD
Imipramine—Ataxia—Lisinopril—dilated cardiomyopathy	0.000946	0.00649	CcSEcCtD
Imipramine—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000918	0.00631	CcSEcCtD
Imipramine—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000916	0.00629	CcSEcCtD
Imipramine—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000909	0.00624	CcSEcCtD
Imipramine—Breast disorder—Lisinopril—dilated cardiomyopathy	0.000909	0.00624	CcSEcCtD
Imipramine—Eye disorder—Furosemide—dilated cardiomyopathy	0.000867	0.00595	CcSEcCtD
Imipramine—Tinnitus—Furosemide—dilated cardiomyopathy	0.000865	0.00594	CcSEcCtD
Imipramine—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000861	0.00591	CcSEcCtD
Imipramine—Pruritus—Spironolactone—dilated cardiomyopathy	0.000857	0.00588	CcSEcCtD
Imipramine—HTR7—heart—dilated cardiomyopathy	0.000853	0.00639	CbGeAlD
Imipramine—Angiopathy—Furosemide—dilated cardiomyopathy	0.000841	0.00578	CcSEcCtD
Imipramine—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000838	0.00575	CcSEcCtD
Imipramine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000828	0.00569	CcSEcCtD
Imipramine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000828	0.00569	CcSEcCtD
Imipramine—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000825	0.00567	CcSEcCtD
Imipramine—ADRA1A—heart—dilated cardiomyopathy	0.000823	0.00617	CbGeAlD
Imipramine—Malnutrition—Furosemide—dilated cardiomyopathy	0.000807	0.00554	CcSEcCtD
Imipramine—Dizziness—Spironolactone—dilated cardiomyopathy	0.000801	0.0055	CcSEcCtD
Imipramine—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000801	0.0055	CcSEcCtD
Imipramine—KCNH2—heart—dilated cardiomyopathy	0.000795	0.00596	CbGeAlD
Imipramine—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000793	0.00545	CcSEcCtD
Imipramine—Weight increased—Lisinopril—dilated cardiomyopathy	0.000791	0.00543	CcSEcCtD
Imipramine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00079	0.00543	CcSEcCtD
Imipramine—Benazepril—ACE—dilated cardiomyopathy	0.000789	0.105	CrCbGaD
Imipramine—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000786	0.0054	CcSEcCtD
Imipramine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00077	0.00529	CcSEcCtD
Imipramine—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000764	0.00525	CcSEcCtD
Imipramine—Rash—Spironolactone—dilated cardiomyopathy	0.000763	0.00524	CcSEcCtD
Imipramine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000763	0.00524	CcSEcCtD
Imipramine—Vision blurred—Furosemide—dilated cardiomyopathy	0.000761	0.00522	CcSEcCtD
Imipramine—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00076	0.00522	CcSEcCtD
Imipramine—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00076	0.00522	CcSEcCtD
Imipramine—Headache—Spironolactone—dilated cardiomyopathy	0.000759	0.00521	CcSEcCtD
Imipramine—Orphenadrine—SCN5A—dilated cardiomyopathy	0.000756	0.101	CrCbGaD
Imipramine—Jaundice—Lisinopril—dilated cardiomyopathy	0.000755	0.00519	CcSEcCtD
Imipramine—Agitation—Furosemide—dilated cardiomyopathy	0.000742	0.00509	CcSEcCtD
Imipramine—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000733	0.00503	CcSEcCtD
Imipramine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000723	0.00497	CcSEcCtD
Imipramine—Leukopenia—Furosemide—dilated cardiomyopathy	0.000723	0.00496	CcSEcCtD
Imipramine—Nausea—Spironolactone—dilated cardiomyopathy	0.000719	0.00494	CcSEcCtD
Imipramine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000696	0.00478	CcSEcCtD
Imipramine—Hallucination—Lisinopril—dilated cardiomyopathy	0.000692	0.00475	CcSEcCtD
Imipramine—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000687	0.00472	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000682	0.00469	CcSEcCtD
Imipramine—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000682	0.00468	CcSEcCtD
Imipramine—KCNH2—cardiac atrium—dilated cardiomyopathy	0.00068	0.00509	CbGeAlD
Imipramine—Dry mouth—Furosemide—dilated cardiomyopathy	0.000672	0.00461	CcSEcCtD
Imipramine—Confusional state—Furosemide—dilated cardiomyopathy	0.000664	0.00456	CcSEcCtD
Imipramine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000659	0.00452	CcSEcCtD
Imipramine—CYP2B6—heart—dilated cardiomyopathy	0.000652	0.00489	CbGeAlD
Imipramine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000649	0.00445	CcSEcCtD
Imipramine—Shock—Furosemide—dilated cardiomyopathy	0.000648	0.00445	CcSEcCtD
Imipramine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000646	0.00444	CcSEcCtD
Imipramine—Flushing—Lisinopril—dilated cardiomyopathy	0.000646	0.00443	CcSEcCtD
Imipramine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000645	0.00443	CcSEcCtD
Imipramine—Skin disorder—Furosemide—dilated cardiomyopathy	0.00064	0.00439	CcSEcCtD
Imipramine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000637	0.00437	CcSEcCtD
Imipramine—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000631	0.00433	CcSEcCtD
Imipramine—Anorexia—Furosemide—dilated cardiomyopathy	0.000628	0.00431	CcSEcCtD
Imipramine—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000627	0.00431	CcSEcCtD
Imipramine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000621	0.00427	CcSEcCtD
Imipramine—Alopecia—Lisinopril—dilated cardiomyopathy	0.000615	0.00422	CcSEcCtD
Imipramine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000609	0.00419	CcSEcCtD
Imipramine—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000606	0.00416	CcSEcCtD
Imipramine—Tension—Lisinopril—dilated cardiomyopathy	0.000594	0.00408	CcSEcCtD
Imipramine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000593	0.00407	CcSEcCtD
Imipramine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000592	0.00406	CcSEcCtD
Imipramine—Nervousness—Lisinopril—dilated cardiomyopathy	0.000588	0.00404	CcSEcCtD
Imipramine—Somnolence—Furosemide—dilated cardiomyopathy	0.000586	0.00402	CcSEcCtD
Imipramine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000573	0.00393	CcSEcCtD
Imipramine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000571	0.00392	CcSEcCtD
Imipramine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000569	0.00391	CcSEcCtD
Imipramine—Fatigue—Furosemide—dilated cardiomyopathy	0.000568	0.0039	CcSEcCtD
Imipramine—Tremor—Lisinopril—dilated cardiomyopathy	0.000567	0.0039	CcSEcCtD
Imipramine—Constipation—Furosemide—dilated cardiomyopathy	0.000563	0.00387	CcSEcCtD
Imipramine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000562	0.00386	CcSEcCtD
Imipramine—Malaise—Lisinopril—dilated cardiomyopathy	0.000546	0.00375	CcSEcCtD
Imipramine—Syncope—Lisinopril—dilated cardiomyopathy	0.000543	0.00373	CcSEcCtD
Imipramine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000543	0.00373	CcSEcCtD
Imipramine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000542	0.00372	CcSEcCtD
Imipramine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000539	0.0037	CcSEcCtD
Imipramine—Palpitations—Lisinopril—dilated cardiomyopathy	0.000535	0.00367	CcSEcCtD
Imipramine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000532	0.00365	CcSEcCtD
Imipramine—HTR2A—heart—dilated cardiomyopathy	0.000532	0.00399	CbGeAlD
Imipramine—Urticaria—Furosemide—dilated cardiomyopathy	0.000523	0.00359	CcSEcCtD
Imipramine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000521	0.00358	CcSEcCtD
Imipramine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000521	0.00358	CcSEcCtD
Imipramine—Anxiety—Lisinopril—dilated cardiomyopathy	0.000514	0.00353	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000512	0.00352	CcSEcCtD
Imipramine—Discomfort—Lisinopril—dilated cardiomyopathy	0.000509	0.0035	CcSEcCtD
Imipramine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000504	0.00346	CcSEcCtD
Imipramine—Confusional state—Lisinopril—dilated cardiomyopathy	0.000498	0.00342	CcSEcCtD
Imipramine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000494	0.00339	CcSEcCtD
Imipramine—Oedema—Lisinopril—dilated cardiomyopathy	0.000494	0.00339	CcSEcCtD
Imipramine—Infection—Lisinopril—dilated cardiomyopathy	0.000491	0.00337	CcSEcCtD
Imipramine—Shock—Lisinopril—dilated cardiomyopathy	0.000486	0.00334	CcSEcCtD
Imipramine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000484	0.00332	CcSEcCtD
Imipramine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000482	0.00331	CcSEcCtD
Imipramine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00048	0.0033	CcSEcCtD
Imipramine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000478	0.00328	CcSEcCtD
Imipramine—Asthenia—Furosemide—dilated cardiomyopathy	0.000473	0.00325	CcSEcCtD
Imipramine—Anorexia—Lisinopril—dilated cardiomyopathy	0.000471	0.00324	CcSEcCtD
Imipramine—Pruritus—Furosemide—dilated cardiomyopathy	0.000466	0.0032	CcSEcCtD
Imipramine—Diphenhydramine—SLC22A5—dilated cardiomyopathy	0.00046	0.0613	CrCbGaD
Imipramine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000451	0.00309	CcSEcCtD
Imipramine—Insomnia—Lisinopril—dilated cardiomyopathy	0.000447	0.00307	CcSEcCtD
Imipramine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000444	0.00305	CcSEcCtD
Imipramine—Somnolence—Lisinopril—dilated cardiomyopathy	0.000439	0.00302	CcSEcCtD
Imipramine—Dizziness—Furosemide—dilated cardiomyopathy	0.000436	0.00299	CcSEcCtD
Imipramine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000435	0.00299	CcSEcCtD
Imipramine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00043	0.00295	CcSEcCtD
Imipramine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000427	0.00293	CcSEcCtD
Imipramine—Fatigue—Lisinopril—dilated cardiomyopathy	0.000426	0.00293	CcSEcCtD
Imipramine—Constipation—Lisinopril—dilated cardiomyopathy	0.000423	0.0029	CcSEcCtD
Imipramine—Vomiting—Furosemide—dilated cardiomyopathy	0.000419	0.00288	CcSEcCtD
Imipramine—Rash—Furosemide—dilated cardiomyopathy	0.000415	0.00285	CcSEcCtD
Imipramine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000415	0.00285	CcSEcCtD
Imipramine—Headache—Furosemide—dilated cardiomyopathy	0.000413	0.00283	CcSEcCtD
Imipramine—Desipramine—SLC22A5—dilated cardiomyopathy	0.00041	0.0546	CrCbGaD
Imipramine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000407	0.0028	CcSEcCtD
Imipramine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000404	0.00278	CcSEcCtD
Imipramine—Urticaria—Lisinopril—dilated cardiomyopathy	0.000393	0.0027	CcSEcCtD
Imipramine—Nausea—Furosemide—dilated cardiomyopathy	0.000391	0.00269	CcSEcCtD
Imipramine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000391	0.00268	CcSEcCtD
Imipramine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000391	0.00268	CcSEcCtD
Imipramine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000355	0.00243	CcSEcCtD
Imipramine—Pruritus—Lisinopril—dilated cardiomyopathy	0.00035	0.0024	CcSEcCtD
Imipramine—ABCB1—heart—dilated cardiomyopathy	0.000349	0.00261	CbGeAlD
Imipramine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000338	0.00232	CcSEcCtD
Imipramine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000327	0.00224	CcSEcCtD
Imipramine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000314	0.00216	CcSEcCtD
Imipramine—Rash—Lisinopril—dilated cardiomyopathy	0.000312	0.00214	CcSEcCtD
Imipramine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000311	0.00214	CcSEcCtD
Imipramine—Headache—Lisinopril—dilated cardiomyopathy	0.00031	0.00213	CcSEcCtD
Imipramine—Nausea—Lisinopril—dilated cardiomyopathy	0.000294	0.00202	CcSEcCtD
Imipramine—Desipramine—ADRB1—dilated cardiomyopathy	0.000283	0.0377	CrCbGaD
Imipramine—Desipramine—ADRB2—dilated cardiomyopathy	0.000238	0.0317	CrCbGaD
Imipramine—CHRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.11e-05	0.00013	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.1e-05	0.000129	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.09e-05	0.000129	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.09e-05	0.000129	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.08e-05	0.000128	CbGpPWpGaD
Imipramine—SLC22A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.08e-05	0.000128	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.08e-05	0.000128	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.07e-05	0.000128	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.07e-05	0.000128	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.07e-05	0.000128	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.04e-05	0.000126	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.02e-05	0.000125	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.02e-05	0.000125	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.02e-05	0.000124	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.01e-05	0.000124	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.01e-05	0.000124	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	1.99e-05	0.000123	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.99e-05	0.000122	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.98e-05	0.000122	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—AGT—dilated cardiomyopathy	1.98e-05	0.000122	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.98e-05	0.000122	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	1.98e-05	0.000122	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.97e-05	0.000122	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.97e-05	0.000121	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.96e-05	0.000121	CbGpPWpGaD
Imipramine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.96e-05	0.000121	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.96e-05	0.00012	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.95e-05	0.00012	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.95e-05	0.00012	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.94e-05	0.00012	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.94e-05	0.000119	CbGpPWpGaD
Imipramine—SLC22A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.93e-05	0.000119	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.93e-05	0.000119	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.93e-05	0.000119	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.92e-05	0.000118	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.91e-05	0.000118	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.91e-05	0.000118	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—AGT—dilated cardiomyopathy	1.9e-05	0.000117	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.9e-05	0.000117	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.89e-05	0.000117	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.89e-05	0.000116	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.88e-05	0.000116	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.88e-05	0.000116	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.88e-05	0.000116	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.88e-05	0.000116	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.88e-05	0.000116	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.87e-05	0.000115	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.87e-05	0.000115	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.87e-05	0.000115	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.87e-05	0.000115	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.87e-05	0.000115	CbGpPWpGaD
Imipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.87e-05	0.000115	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.86e-05	0.000115	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.86e-05	0.000115	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.86e-05	0.000115	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.86e-05	0.000114	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.85e-05	0.000114	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.85e-05	0.000114	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.84e-05	0.000114	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.84e-05	0.000113	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.84e-05	0.000113	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.84e-05	0.000113	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.83e-05	0.000113	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.82e-05	0.000112	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.8e-05	0.000111	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.8e-05	0.000111	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.79e-05	0.00011	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.79e-05	0.00011	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.78e-05	0.000109	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.77e-05	0.000109	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.76e-05	0.000109	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.76e-05	0.000109	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.76e-05	0.000108	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.75e-05	0.000108	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.75e-05	0.000108	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.74e-05	0.000107	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.74e-05	0.000107	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.74e-05	0.000107	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.73e-05	0.000107	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	1.72e-05	0.000106	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.72e-05	0.000106	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—AGT—dilated cardiomyopathy	1.72e-05	0.000106	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.72e-05	0.000106	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	1.71e-05	0.000106	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.71e-05	0.000105	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—AGT—dilated cardiomyopathy	1.71e-05	0.000105	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.69e-05	0.000104	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.69e-05	0.000104	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.69e-05	0.000104	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.69e-05	0.000104	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	1.69e-05	0.000104	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.68e-05	0.000104	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.68e-05	0.000103	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.67e-05	0.000103	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—RAC1—dilated cardiomyopathy	1.66e-05	0.000103	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.66e-05	0.000103	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.66e-05	0.000103	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—RAC1—dilated cardiomyopathy	1.66e-05	0.000102	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.66e-05	0.000102	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.66e-05	0.000102	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	1.6e-05	9.86e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—GPX1—dilated cardiomyopathy	1.6e-05	9.84e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.59e-05	9.82e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—AGT—dilated cardiomyopathy	1.59e-05	9.8e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—AGT—dilated cardiomyopathy	1.59e-05	9.79e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.59e-05	9.78e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.59e-05	9.78e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.58e-05	9.73e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—RAC1—dilated cardiomyopathy	1.57e-05	9.68e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.57e-05	9.64e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.56e-05	9.64e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	1.56e-05	9.6e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—CD36—dilated cardiomyopathy	1.56e-05	9.59e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.52e-05	9.39e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.51e-05	9.31e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—RAC1—dilated cardiomyopathy	1.5e-05	9.27e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—AGT—dilated cardiomyopathy	1.5e-05	9.25e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—GPX1—dilated cardiomyopathy	1.49e-05	9.18e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.47e-05	9.05e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—CD36—dilated cardiomyopathy	1.45e-05	8.94e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.45e-05	8.91e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.44e-05	8.89e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.44e-05	8.86e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—AGT—dilated cardiomyopathy	1.44e-05	8.85e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.43e-05	8.83e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.42e-05	8.75e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.42e-05	8.72e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—RAC1—dilated cardiomyopathy	1.41e-05	8.71e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	1.4e-05	8.65e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—AGT—dilated cardiomyopathy	1.4e-05	8.63e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.39e-05	8.59e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.38e-05	8.52e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.38e-05	8.48e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—GPX1—dilated cardiomyopathy	1.38e-05	8.48e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.37e-05	8.45e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.37e-05	8.45e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.37e-05	8.43e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.36e-05	8.4e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.36e-05	8.4e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.36e-05	8.38e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.36e-05	8.36e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—AGT—dilated cardiomyopathy	1.35e-05	8.32e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.35e-05	8.3e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.34e-05	8.27e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—CD36—dilated cardiomyopathy	1.34e-05	8.25e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.32e-05	8.12e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—AGT—dilated cardiomyopathy	1.31e-05	8.05e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.3e-05	8e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.28e-05	7.9e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.28e-05	7.89e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.23e-05	7.59e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	1.23e-05	7.55e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.21e-05	7.48e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.21e-05	7.45e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—AGT—dilated cardiomyopathy	1.21e-05	7.43e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.2e-05	7.38e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.2e-05	7.36e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.19e-05	7.35e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.19e-05	7.32e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.18e-05	7.3e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	1.18e-05	7.29e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.18e-05	7.26e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	1.18e-05	7.26e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.18e-05	7.25e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—RAC1—dilated cardiomyopathy	1.17e-05	7.23e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.17e-05	7.23e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.17e-05	7.22e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	1.17e-05	7.22e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.17e-05	7.21e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.17e-05	7.2e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	1.16e-05	7.14e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.16e-05	7.13e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.16e-05	7.13e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.15e-05	7.11e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	1.15e-05	7.1e-05	CbGpPWpGaD
Imipramine—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.13e-05	6.99e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	1.13e-05	6.96e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—AGT—dilated cardiomyopathy	1.12e-05	6.91e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—RAF1—dilated cardiomyopathy	1.1e-05	6.8e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—RAF1—dilated cardiomyopathy	1.1e-05	6.79e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.09e-05	6.71e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.08e-05	6.67e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.06e-05	6.56e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.06e-05	6.55e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.06e-05	6.52e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—RAC1—dilated cardiomyopathy	1.06e-05	6.5e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.05e-05	6.44e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.04e-05	6.42e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—RAF1—dilated cardiomyopathy	1.04e-05	6.42e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	1.04e-05	6.39e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	1.03e-05	6.37e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	1.02e-05	6.27e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	1.02e-05	6.26e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—AGT—dilated cardiomyopathy	1.02e-05	6.25e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	1.01e-05	6.23e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—AGT—dilated cardiomyopathy	1.01e-05	6.21e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	9.99e-06	6.15e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—RAF1—dilated cardiomyopathy	9.97e-06	6.14e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	9.96e-06	6.14e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.49e-06	5.84e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.44e-06	5.81e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—RAF1—dilated cardiomyopathy	9.38e-06	5.78e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.03e-06	5.57e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	8.94e-06	5.51e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	8.73e-06	5.38e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	8.71e-06	5.37e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—CD36—dilated cardiomyopathy	8.5e-06	5.24e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.33e-06	5.13e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	8.23e-06	5.07e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.2e-06	5.05e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.18e-06	5.04e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	8.17e-06	5.04e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.15e-06	5.02e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	8.13e-06	5.01e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.13e-06	5.01e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.05e-06	4.96e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.02e-06	4.94e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	8.01e-06	4.94e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	7.84e-06	4.83e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—RAF1—dilated cardiomyopathy	7.78e-06	4.8e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—AGT—dilated cardiomyopathy	7.65e-06	4.72e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—EGFR—dilated cardiomyopathy	7.57e-06	4.66e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—EGFR—dilated cardiomyopathy	7.56e-06	4.66e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	7.21e-06	4.44e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	7.17e-06	4.42e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—EGFR—dilated cardiomyopathy	7.14e-06	4.4e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	7.06e-06	4.35e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—RAF1—dilated cardiomyopathy	7.04e-06	4.34e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	7.02e-06	4.33e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—RAF1—dilated cardiomyopathy	7e-06	4.31e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	6.97e-06	4.29e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	6.93e-06	4.27e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	6.91e-06	4.26e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—EGFR—dilated cardiomyopathy	6.84e-06	4.21e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	6.79e-06	4.18e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—EGFR—dilated cardiomyopathy	6.43e-06	3.96e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	6.11e-06	3.76e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	5.6e-06	3.45e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	5.58e-06	3.44e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	5.38e-06	3.31e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—EGFR—dilated cardiomyopathy	5.34e-06	3.29e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	5.24e-06	3.23e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	4.92e-06	3.03e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	4.84e-06	2.98e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—EGFR—dilated cardiomyopathy	4.83e-06	2.98e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	4.82e-06	2.97e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—EGFR—dilated cardiomyopathy	4.8e-06	2.96e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	4.75e-06	2.93e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	4.74e-06	2.92e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	4.72e-06	2.91e-05	CbGpPWpGaD
